Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20262)

Formulation Name
Sirolimus 0.5 mg tablet
Company
Cadila Healthcare
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Sirolimus DMGW1ID Advanced cancer 2A00-2F9Z Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Citric acid monohydrate E00271 22230 Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Hydrazine yellow E00409 164825 Colorant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Poloxamer 188 E00645 Not Available Emulsifying agent; Solubilizing agent; Surfactant
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Saccharose E00091 5988 Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Tocopheryl acetate E00053 86472 Antioxidant